From drug discovery to diagnostics , population-level patient data has a powerful role to play in overcoming the biggest health challenges of our generation . Dr Petros Kotsidis , Chief Data Officer at FITFILE , explores how properly-managed health data could be used to accelerate progress in the life sciences sector and how existing barriers to progress can be overcome .
WHY UNLOCKED PATIENT DATA COULD HOLD THE KEY TO TACKLING DISEASE ON A GLOBAL SCALE
According to research and analysis carried out by the WHO , the top 10 most common diseases and health conditions account for approximately 55 % of the 55.4 million annual deaths . Including cardiovascular diseases , respiratory conditions and neonatal conditions , these illnesses pose a huge obstacle to governments ’ efforts to ensure healthy lives and improve well-being for all ages ( WHO ’ s 2030 Sustainable Development Goal 3 ).
One positive consequence of these conditions ’ high incidence is that national health systems hold vast quantities of data on their causation , diagnosis , progression and transmission . This is data that could be key to reducing disease morbidity and mortality , with use cases including drug discovery , accelerated diagnostic pathways and epidemic prevention .